https://www.selleckchem.com/pr....oducts/acetylcystein
3% vs 55.4%; = 0.05). They were also more likely to strongly agree that a diagnosis of FH was important to them (71.1% vs 46.2%; = 0.008), and were more likely to recommend genetic screening to their family members (85.9% vs 72.9%; = 0.04). To our knowledge, this is the first study in Canada to explore the perspectives of patients with FH who underwent genetic testing. These results suggest that genetic testing for FH might offer benefits in important patient-centred outcomes. To our knowledge, this is the first study in Canada t
Me gusta
Comentario
Compartir
